A Phase 1 Trial of MK-3475 Plus Ziv-Aflibercept in Patients With Advanced Solid Tumors
Phase of Trial: Phase I
Latest Information Update: 30 Nov 2017
At a glance
- Drugs Aflibercept (Primary) ; Pembrolizumab (Primary)
- Indications Colorectal cancer; Malignant melanoma; Ovarian cancer; Renal cell carcinoma; Solid tumours
- Focus Adverse reactions
- 10 Jun 2017 Biomarkers information updated
- 21 Apr 2017 Planned primary completion date changed from 1 Apr 2017 to 1 Dec 2018.
- 28 Jul 2016 Planned primary completion date changed from 1 Jul 2016 to 1 Apr 2017.